COMMUNIQUÉS West-GlobeNewswire

Helius Medical Technologies Announces Positive Results from its Registrational Clinical Trial for Traumatic Brain Injury (TBI)
09/11/2017
NEWTOWN, Pa., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (TSX: HSM ) (OTCQB:HSDT) ("Helius" or the "Company"), a medical technology company focused on neurological wellness, announced results [...]
RadNet Reports Third Quarter Financial Results and Reaffirms Previously Announced 2017 Guidance Levels
09/11/2017
Total Net Revenue (“Revenue”) increased 1.3% to $227.6 million in the third quarter of 2017 from $224.6 million in the third quarter of 2016: Adjusting for the sale of the Rhode Island facilities, Revenue increased 1.9 [...]
Crown Bioscience Inc. Announcing the 2017 Board of Directors Election Results
09/11/2017
TAIPEI, Taiwan, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development services company providing [...]
Ossur Hf : Management Changes
09/11/2017
Announcement Össur hf. No. 81/2017 Reykjavik, 9 November 2017 New R&D leadership Dr. Thorvaldur Ingvarsson, EVP of Research & Development (R&D), has decided to leave Össur after leading the R&D function [...]
Share Capital and Votes
09/11/2017
Pursuant to section 10 of executive order no. 1526 of December 9, 2016 on Issuers' Disclosure Obligations, it is hereby announced, that BioPorto A/S total share capital amounts to DKK 155.509.681 divided into shares of [...]
Bavarian Nordic Announces Initiation of Phase 2 Booster Study of its Universal RSV Vaccine
09/11/2017
Study to help determine if MVA-BN RSV will be administered as a seasonal vaccine or if a single shot is effective for multiple seasons COPENHAGEN, Denmark, November 9, 2017 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) [...]
VALNEVA publie une très forte performance opérationnelle sur les neufs premiers mois de l'exercice 2017
09/11/2017
Valneva publie une très forte performance opérationnelle sur les neufs premiers mois de l'exercice 2017 La forte performance opérationnelle sur les neuf premiers mois de l'exercice 2017 et les perspectives annuelles [...]
VALNEVA Reports Strong Operational Performance for the First Nine Months of 2017
09/11/2017
Valneva Reports Strong Operational Performance for the First Nine Months of 2017 Strong financial performance for first nine months of 2017 and full year outlook leads to upward revision of EBITDA guidance Total [...]
ABLYNX TO PRESENT AT UPCOMING INVESTOR CONFERENCES IN LONDON AND PARIS
09/11/2017
GHENT, Belgium, 9 November 2017 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announces that it will participate in the following upcoming investor conferences taking place in London, UK and Paris, France: [...]
Apellis Pharmaceuticals Announces Pricing of Initial Public Offering
09/11/2017
CRESTWOOD, Ky., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (NASDAQ: APLS ), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease [...]
Sarepta Therapeutics Prices $475 Million of Convertible Senior Notes Due 2024
09/11/2017
CAMBRIDGE, Mass., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicines to [...]
Telix Pharmaceuticals Limited Successfully Completes $50 Million Oversubscribed Initial Public Offering
09/11/2017
MELBOURNE, Australia, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of diagnostic and therapeutic products [...]
New Eftilagimod Alpha (LAG-3Ig or IMP321) Data for Presentation at the Society for Immunotherapy of Cancer (SITC) 2017 Annual Meeting
08/11/2017
SYDNEY, Australia, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Prima BioMed Ltd (ASX:PRR) (NASDAQ: PBMD ) (“Prima”) is pleased to announce the presentation of new data from its TACTI-mel Phase I clinical trial in Australia [...]
Cocrystal Pharma Announces Filing 2017 Third Quarter Financial Statements and Provides Company Update
08/11/2017
ATLANTA, GA and BOTHELL, WA, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (OTCQB: COCP), a company focused on developing novel antiviral therapeutics for human diseases, today announced the filing of its [...]
Atrion Corporation Declares Quarterly Cash Dividend
08/11/2017
ALLEN, Texas, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Atrion Corporation (Nasdaq: ATRI ) today announced that its Board of Directors declared a quarterly cash dividend of $1.20 per share on the Company’s outstanding Common [...]
ZoomMed Announces the Closing of a $500,000 Financing Agreement
08/11/2017
BROSSARD, Quebec, Nov. 08, 2017 (GLOBE NEWSWIRE) -- ZoomMed Inc. (TSX-V: ZMD ) announces the closing of a $500,000 secured financing agreement with a private investor dealing at arm’s length with ZoomMed. The loan bears [...]
ZoomMed annonce la clôture d’un financement de 500,000 $
08/11/2017
BROSSARD, Quebec, 08 nov. 2017 (GLOBE NEWSWIRE) -- ZoomMed Inc. (TSX CROISSANCE:ZMD) annonce la clôture d’un financement garanti au montant de 500 000 $ avec un investisseur privé traitant à distance avec ZoomMed. Le [...]
Spine Injury Solutions Schedules Interactive Conference Call to Present 3rd Quarter 2017 Financial Results, Provide Business Development Update
08/11/2017
HOUSTON, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Spine Injury Solutions, Inc. (OTCQB:SPIN), a technology-driven, medical service, and healthcare solution company servicing the multi-billion dollar spine injury sector, through [...]
Genmab Announces Financial Results for the First Nine Months of 2017
08/11/2017
November 8, 2017; Copenhagen, Denmark; Interim Report for the First Nine Months Ended September 30, 2017 Highlights USD 871 million in net sales of DARZALEX ® (daratumumab); resulting in royalty income of DKK 707 [...]

Pages